Animalcare Group plc (ANCR) Q4 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

morning. It looks like we've got a fair number of participants online, so we'll kick off. I think most of you know myself and Chris, so CEO, CFO, and we're delighted to be able to share with you our results this morning. Usual process, this is being recorded. If you have a question, if you put your a virtual hand up. And at the end of the presentation, Helen, who's helping us from Stifel, will unmute you and get you to ask your question. And we're more than happy to take whatever questions, but it's easier if we do them at the end on a virtual programme like this. So we'll get going. And again, thank you for joining us. I'd just like to start by reassuring those of you who've been very used to our five pillars that we haven't really changed our strategy at all. So we've just expressed it slightly differently just to pick up really the progress in the organisation. So what you can see here, the three boxes, we now talk about our organic growth. I think we used to talk about the portfolio. It's exactly the same strategic priority, really looking at developing and nurturing our existing veterinary brands. The inorganic growth, which we'll talk a bit more about because that is a really important part of our strategy, making sure that we are looking for the right strategically aligned opportunities for inorganic growth. And we'll touch on that a little bit more. Nothing's changed about that. Still geographic reach, building scale and strengthening both short, mid and long term pipelines. Moving on to the right hand side, new product development. So really for us, the inorganic growth is feeding the left hand side and feeding the right hand side. So feeding into organic growth in the next few years and feeding into new product development in the longer term. The other pill...